首页> The Prostate> p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.

p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.

导出原文传递

翻译打印收藏纠错

第一作者： Isharwal S

作者： Isharwal S ^[1] ; Miller MC ; Marlow C ; Makarov DV ; Partin AW ; Veltri RW

作者单位： James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. ^[1]

关键词 GLEASON GRADING FOR PROSTATIC CANCER Recurrence Cancer of Prostate Neoplasms 复发肿瘤

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Prostate

2008年68卷10期

1097-1104页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

The Prostate

2008年68卷10期

1097-1104页

检索历史清除

p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.

The Prostate

相似文献

同项目论文

The Prostate

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.

The Prostate

相似文献

同项目论文

The Prostate

相关期刊

检索历史清除